Cancer/testis antigen expression in human mesenchymal stem cells: Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression

Cancer Research

Volumn 65, Issue 6, 2005, Pages 2207-2215

  Cronwright, Garth ^a   Le Blanc, Katarina ^a,b   Götherström, Cecilia ^a   Darcy, Pádraig ^a   Ehnman, Monika ^a   Brodin, Bertha ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; CELL MARKER; GELATINASE A; TUMOR ANTIGEN; UVOMORULIN; VIMENTIN;

ADIPOCYTE; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; DOWN REGULATION; FETUS; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA CELL; MESENCHYMAL STEM CELL; METASTASIS; MOLECULAR DYNAMICS; MOLECULAR MIMICRY; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SSX GENE;

ANTIGENS, NEOPLASM; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; HUMANS; MATRIX METALLOPROTEINASE 2; MELANOMA; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; NEOPLASM PROTEINS; REPRESSOR PROTEINS; VIMENTIN;

EID: 16844362032     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1882     Document Type: Article

References (66)

1. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994;12:337-65.
2. Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 1997;94:1914-8.
3. Old LJ. Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun 2001;30:1-10.
4. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004;4:1.
5. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. Science 1991;254:1643-7.
6. Gure AO, Tureci O, Sahin U, et al. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997;72:965-71.
7. Jager D, Unkelbach M, Frei C, et al. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2002;2:5.
8. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1998;22:5640-8.
9. Brinkmann U, Vasmatzis G, Lee B, Yerushalmi N, Essand M, Pastan I. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proc Natl Acad Sci U S A 1998;95:10757-62.
10. Lucas S, De Plaen E, Boon T. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. Int J Cancer 2000;87:55-60.
11. Scanlan MJ, Altorki NK, Gure AO, et al. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett 2000;150:155-64.
12. Renkvist N, Castelli C, Robbins PF, Parmiani G. A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 2001;50:3-15.
13. dos Santos NR, Torensma R, de Vries TJ, et al. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 2000;60:1654-62.
14. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
15. Brickman JM, Burdon TG. Pluripotency and tumorigenicity. Nat Genet 2002;32:557-8.
16. Nakagawara A. Neural crest development and neuroblastoma: the genetic and biological link. Prog Brain Res 2004;146:233-42.
17. Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003;194:272-88.
18. Friedenstein AJ, Petrakova KV, Kuroksova AI. Heterotopic transplants of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissue. Transplantation 1968;6:230-47.
19. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
20. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic. Science 1997;276:71-4.
21. Campagnioli C, Roberts IA, Kumar S. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396-402.
22. Götherström C, Ringdén O, Westgren M, Tammik C, Le Blanc K. Immunomodulatory effects of human fetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 2003;32:265-72.
23. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
24. Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol 2002;30:870-8.
25. Angelopolou M, Novelli E, Grove J, et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoeisis in NOD/SCID mice. Exp Hematol 2003;31:413-20.
26. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-9.
27. Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP. Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci U S A 1995;92:4987-91.
28. Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998;58:743-52.
29. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001;61:5544-51.
30. De Backer O, Arden KC, Boretti M, et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999;59:3157-65.
31. Brinkmann U, Vasmatzis G, Lee B, Pastan I. Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database. Cancer Res 1999;59:1445-8.
32. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. Cancer Res 2000;60:4752-5.
33. Wang T, Fan L, Watanabe Y, et al. L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma. Oncogene 2001;20:7699-709.
34. Zendman AJ, Van Kraats AA, Weidle UH, Ruiter DJ, Van Muijen GN. The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer 2002;99:361-9.
35. Chen YT, Boyer AD, Viars CS, Tsang S, Old LJ, Arden KC. Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. Cytogenet Cell Genet 1997;79:237-40.
36. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X:18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-8.
37. Kato H, Tjernberg A, Zhang W, et al. SYT associates with human SNF/SW1 complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 2002;277:5498-505.
38. Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC. A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 1998;17:2013-8.
39. Soulez M, Saurin AJ, Freemont PS, Knight JC. SSX and the synovial-sarcoma-specific chimeric protein SYT-SSX co-localizes with the human Polycomb group complex. Oncogene 1999;18:2739-46.
40. de Bruijn DR, dos Santos NR, Kater-Baats E, et al. The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP. Genes Chromosomes Cancer 2002;34:285-98.
41. Silva WA Jr, Covas DT, Panepucci RA, et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003;21:661-9.
42. dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, van Kessel AG. Delineation of the protein domains responsible for SYT, SSX and SYT-SSX nuclear localization. Exp Cell Res 2000;256:192-202.
43. Pulyaeva H, Bueno J, Polette M, et al. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 1997;15:111-20.
44. Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003;63:1138-43.
45. Lennon DP, Haynesworth SE, Bruder SP, et al. Development of a serum screen for mesenchymal progenitor cells from bone marrow. In Vitro Cell Dev Biol 1996;32:602-11.
46. Le Blanc K, Tammik L, Zetterberg E, Rosendahl K, Ringdén O. HLA-expression and immunologic properties of undifferentiated and differentiated mesenchymal stem cells. Exp Hematol 2003;31:890-6.
47. Chen YT, Alpen B, Ono T, et al. Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression. Genomics 2003;82:628-36.
48. Jungbluth A, Busam K, Kolb D, et al. Expression of MAGE antigens in normal tissue and cancer. Int J Cancer 2000;85:460-5.
49. Jungbluth A, Busam K, Iversen K, et al. Cancer/testis antigens: structural and immunobiological properties. Cancer Invest 2002;20:222-36.
50. Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994;70:6-22.
51. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A 2003;100 Suppl 1:11842-9.
52. Perez-Losada J, Balmain A. Stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003;3:434-43.
53. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7.
54. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci U S A 2003;100:3547-9.
55. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8.
56. Schultz-Thater E, Noppen C, Gudat F, et al. NY-ESO-1 tumor associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. Br J Cancer 2000;83:204-8.
57. Drayton S, Peters G. Immortalisation and transformation revisited. Curr Opin Genet Dev 2002;12:98-104.
58. Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002;16:2991-3003.
59. Götherström C, Ringdén O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. Immunological properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004;190:238-44.
60. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-97.
61. Majumdar M, Keane-Moore M, Buyaner D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003;10:228-41.
62. Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes (CTL), but not activated CTL or natural killer (NK) cells. Transplantation 2003;76:1208-13.
63. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57:11-20.
64. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-8.
65. Thompson EW, Price JT. Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets 2002;6:217-33.
66. Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. Cancer/testis antigens: structural and immunobiological properties. Cancer Invest 2002;20:222-36.